EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California. The expansion comes in anticipation of California’s new 2018 testing rules and includes a full suite of testing services, such as pesticide, microbiological and expanded cannabinoid potency testing. “We are getting feedback directly from clients on the ground in California that is similar to what we experienced in Oregon back in 2015 when we opened our first lab in Oregon a full year before the official rollout of their testing requirements,” William Waldrop, CEO of EVIO, stated in the news release. “We anticipate California will play out in a very similar fashion, albeit on a much grander and profitable scale, as California is projected to be largest retail cannabis marketplace on earth. California’s cannabis market is forecasted to have at least 10 times market opportunity for analytical testing revenues over Oregon where EVIO currently tests close to 25% of all cannabis products on the shelves for sale in the state.”
To view the full press release, visit http://cnw.fm/wrL9f
About EVIO, Inc.
EVIO, Inc. is an Oregon-based life sciences company that provides analytical testing services, management advisory services and scientific research to the legal cannabis and hemp industries. The Company’s EVIO Labs division operates state-of-the-art facilities and offers accredited testing methodologies to ensure the safety and quality of the nation’s cannabis supply. Learn more at www.EvioLabs.com or the Company can be reached directly @ 1-888-544-EVIO.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com